Stockreport

PrBIMZELX® (bimekizumab injection) approved in Canada for treatment of moderate to severe hidradenitis suppurativa (HS) [Yahoo! Finance]

UCB SA UNSP/ADR  (UCBJY) 
NASDAQ:AMEX Investor Relations: ucb.com/investors
PDF patients' disease activity globally compared to placebo at Week 16 with Hurley Stage II/III HS and inadequate response to antibiotics when treated with Pr BIMZELX ® (bim [Read more]